
Sign up to save your podcasts
Or


Jeff talks about building Facebook's early data team, founding Cloudera, and transitioning into biomedicine with Hammer Lab and Related Sciences.
(Read more: http://wandb.me/gd-jeff-hammerbacher)
---
Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff's current work focuses on drug discovery at Related Sciences, a biotech venture creation firm that he co-founded in 2020.
Prior to his work at Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, and the manager of the Data team at Facebook.
---
Follow Gradient Dissent on Twitter: https://twitter.com/weights_biases
---
0:00 Sneak peek, intro
1:13 The start of Facebook's data science team
6:53 Facebook's early tech stack
14:20 Early growth strategies at Facebook
17:37 The origin story of Cloudera
24:51 Cloudera's success, in retrospect
31:05 Jeff's transition into biomedicine
38:38 Immune checkpoint blockade in cancer therapy
48:55 Data and techniques for biomedicine
53:00 Why Jeff created Related Sciences
56:32 Outro
By Lukas Biewald4.8
6868 ratings
Jeff talks about building Facebook's early data team, founding Cloudera, and transitioning into biomedicine with Hammer Lab and Related Sciences.
(Read more: http://wandb.me/gd-jeff-hammerbacher)
---
Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff's current work focuses on drug discovery at Related Sciences, a biotech venture creation firm that he co-founded in 2020.
Prior to his work at Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, and the manager of the Data team at Facebook.
---
Follow Gradient Dissent on Twitter: https://twitter.com/weights_biases
---
0:00 Sneak peek, intro
1:13 The start of Facebook's data science team
6:53 Facebook's early tech stack
14:20 Early growth strategies at Facebook
17:37 The origin story of Cloudera
24:51 Cloudera's success, in retrospect
31:05 Jeff's transition into biomedicine
38:38 Immune checkpoint blockade in cancer therapy
48:55 Data and techniques for biomedicine
53:00 Why Jeff created Related Sciences
56:32 Outro

530 Listeners

1,081 Listeners

302 Listeners

339 Listeners

232 Listeners

268 Listeners

212 Listeners

89 Listeners

488 Listeners

133 Listeners

96 Listeners

209 Listeners

560 Listeners

36 Listeners

41 Listeners